Business Context and Reporting Period
CareDx, Inc. (CDNA) filed a Form 8-K on May 9, 2024, to report its financial results for the quarter ended March 31, 2024. The filing incorporates by reference a press release (Exhibit 99.1) and an earnings presentation (Exhibit 99.2) containing the detailed operational and financial data.
Key Financial Metrics
The provided Form 8-K text serves as a cover document and does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are located in the attached exhibits (99.1 and 99.2) which are not included in the input text.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors must refer to the attached press release and earnings presentation for comparative analysis.
Guidance, Outlook, and Risks
The filing text does not include specific guidance, outlook, management commentary, risks, contingencies, or unusual items. This information is contained within the referenced exhibits.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q1 2024 revenue and net loss figures.
- Examine Exhibit 99.2 (Earnings Presentation) for updated full-year guidance and cash runway details.
- Verify the company's burn rate and liquidity position as disclosed in the attached financial statements.
- Check for any updates on product pipeline or regulatory approvals mentioned in the management commentary.